Metcash Limited
.png)
MTS Details
-
Attractive valuations: Metcash Limited (ASX: MTS) rallied over 6.1% on May 20, 2016 driven by the analyst upgrade by Credit Suisse with $2.25 price target. MTS have been divesting its non-core business (Burson group) and have been in the news on its potential acquisition of Woolworths’ Masters Home Improvement business.
-
Recommendation: We believe the stock has some more room for growth and hence maintain a “Hold” on the stock at the current price of $1.982
Mayne Pharma Group Ltd
MYX Details
-
Strong pipeline: Mayne Pharma Group Ltd (ASX: MYX) rose over 4.4% on May 20, 2016 even though there is no specific update from the group. The group has been enhancing its investments in R&D to advance global pipeline with 18 products pending approval at FDA and is targeting markets with sales of greater than US$2 billion. The group’s Doryx acquisition has surpassed EBITDA guidance of US$2.7 million per month over the first half of 2016.
-
Recommendation: We believe that MYX is trading at a reasonably high valuations with an expensive P/E. Hence, we give an “Expensive” recommendation on the stock at the current price of $1.405
Doryx highlights (Source: Company Reports)
Disclaimer
The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkine.com.au and associated pages are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376).The information on this website has been prepared from a wide variety of sources, which Kalkine Pty Ltd, to the best of its knowledge and belief, considers accurate. You should make your own enquiries about any investments and we strongly suggest you seek advice before acting upon any recommendation. Kalkine Pty Ltd has made every effort to ensure the reliability of information contained in its newsletters and websites. All information represents our views at the date of publication and may change without notice. To the extent permitted by law, Kalkine Pty Ltd excludes all liability for any loss or damage arising from the use of this website and any information published (including any indirect or consequential loss, any data loss or data corruption). If the law prohibits this exclusion, Kalkine Pty Ltd hereby limits its liability, to the extent permitted by law to the resupply of services. There may be a product disclosure statement or other offer document for the securities and financial products we write about in Kalkine Reports. You should obtain a copy of the product disclosure statement or offer document before making any decision about whether to acquire the security or product. The link to our Terms & Conditions has been provided please go through them and also have a read of the Financial Services Guide. On the date of publishing this report (mentioned on the website), employees and/or associates of Kalkine Pty Ltd currently hold positions in: BHP, BKY, KCN, PDN, and RIO. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.